치은 섬유모세포에서 Triclosan에 의한 Prostaglandin $E_2$ 합성 억제 = Triclosan Inhibition of Prostaglandin $E_2$ Production in Human Gingival Fibroblast

다국어 초록 (Multilingual Abstract)

The triclosan was shown to have anti-microbial and anti-inflammatory effect with inhibition of inflammatory mediators such as prostaglandin $E_2(PGE_2)$. The purpose of this study was to elucidate whether and how $PGE_2$ could be inhibited by triclosan in human gingival fibroblast. Human gingival fibroblast-1 cells (ATCC CRL2014) were pre-treated for 1 hour with triclosan (0.001 ${\mu}/ml{\sim}10$ ${\mu}/ml$) and then stimulated with $TNF-{\alpha}$ (1.0 ng/ml). $PGE_2$ synthesis was evaluated by ELISA and gene expression of COX-1 and COX-2 was evaluated by RT-PCR after $TNF-{\alpha}$, triclosan, and NS-398 (COX-2 inhibitor, 5, ${\mu}M$) and/ or cycloheximide (protein synthesis inhibitor, 2 ${\mu}g/ml$). Triclosan was cytotoxic to human gingival fibroblasts in the concentration higher than 1.0 ${\mu}g/ml$ for longer than 24 hours in tissue culture. The $PGE_2$ synthesis was inhibited by triclosan in dose-dependent manner. Greater COX-2 mRNA suppression was observed with triclosan (0.1 ${\mu}g/ml$) than with $TNF-{\alpha}$ alone, without change in COX-1 gene expression. Inhibitory effects of triclosan on $PGE_2$ synthesis disappeared in presence of cycloheximide. This study suggests that triclosan inhibit prostaglandin $E_2$ at the level of COX-2 gene regulation and require de novo protein synthesis.

참고문헌 (Reference)

1 "a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects which causes minimal stomach lesion" 105-398 110, 1993

2 "Triclosan; cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro" 106 : 628-636, 1998

3 "Triclosan reduces prostaglandin biosynthesis in human gingival fibroblasts challenged with interleukin-1 in vitro" 23 : 927-933, 1996

4 "Triclosan inhibits histamin-induced inflammation in human skin" 22 : 423-426, 1995

5 "The role of prostaglandins in the regulation of bone metabolism" 313 : 36-46, 1995

6 "The effects of interleukin -1 and 6 in gingival crevicular fluid implication for the pathogenesis of periodontal disease. J Periodontal Res 25" 156-163, 1990.

7 "The effect of triclosan on mediators of gingival inflammation" 22 : 480-484, 1995

8 "The effect of interleukin-1 on collagenolytic activity and prostaglandin E secretion by human periodontal ligament and gingival fibroblast. Archs Oral Biol 33" 237-243, 1988.

9 "TNF-α induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen activated protein kinase and Iκ B kinase 1/2 in human alveolar epithelial cells" 59 : 493-500, 2001

10 "Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation" 45 : 753-755, 1993

11 "Selective cyclooxygenase-2 inhibitor" 25 : 359-378, 1999.

12 "Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats" 71 : 1009-1014, 2000

13 "Role of cytokines and inflammatory mediators in tissue destruction" 28 : 500-510, 1993

14 "Recent advances in plaque" 63-70, 1994

15 "Percutaneous absorption and metabolism of Irgasan DP 300" 3 : 33-47, 1975

16 "NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro" 47 : 55-59, 1995

17 "Modulation of host PGE2 secretion as a determinant of periodontal disease expression" 64 : 432-444, 1993

18 "Involvement of tyrosin kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin -1 β and epidermal growth factor" 257 : 528-532, 1999

19 "Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphoneuclear leukocytes" Gimbrone MA Jr 2003-2011, 1985

20 "Inflammatory mediators and immunoglobulins in GCF from healthy" 543-546, 1993

21 "Induction of interleukin-1γ and -6 in human gingival fibroblast cultures stimulated by bacteroides lipopolysaccharides. Infect Immun 59" 295-301, 1991.

22 "Identification of an inducible endothelial leukocyte adhesion molecule" Gimbrone MA 9238-9242, 1987

23 "Harrison's principles of internal medicine" McGraw Hill 1543-, 1994

24 "Efficacy of the antimicrobial agent triclosan in topical deodorant products recent development in vivo" 223-231, 1987

25 "Effects of oral rinsing with triclosan and sodium lauryl sulfate on dental plaque formation" Ogaard B 192-1951993.

26 "Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss" 207-213, 1992

27 "Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1β release from rat periosteal and human gingival fibroblasts in vitro. Oral Microbiol Immunol 6" 378-380, 1991.

28 "Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms" 306 : 247-251, 1995

29 "Does the nature of solvent affect the anti-inflamatory capacity of triclosan? An experimental study" 24 : 124-128, 1997

30 "Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs)" 107 (107): 11S-17S, 1999

31 "Cyclooxygenase 1 and 2" 38 : 97-120, 1998

32 "Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts" 111 : 445- 454, 1996

33 "Bacterial invasion of the periodontium in a case of juvenile periodontitis" 93-101, 1982

34 "Bacterial invasion of advanced periodontitis in humans. J Periodontol 53" 217-222, 1982.

35 "Antiplaque, antibacterial and anti-inflammatory properties of triclosan mouthrinses in combination with zinc citrate or polyvinylmethylether maleic acid (PMV-MA) copolymer" 104 : 529-534, 1996.

36 "Antimicrobial spectrum of triclosan a broad spectrum antimicrobial agent for topical application II Comparison with some other antimicrobial agents" 72-158 79, 1978